A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction

Journal of Experimental Medicine

Volumn 185, Issue 12, 1997, Pages 2053-2060

  Carbone, Ennio ^a,b   Ruggiero, Giuseppina ^a   Terrazzano, Giuseppe ^a   Palomba, Carmen ^a   Manzo, Ciro ^b   Fontana, Silvia ^c   Spits, Hergen ^d   Kärret, Klas ^e   Zappacosta, Serafino ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CNR   (Italy)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KILLER CELL; LIGAND BINDING; MOLECULAR INTERACTION; MULTIGENE FAMILY; PRIORITY JOURNAL; TARGET CELL;

ANTIGENS, CD3; ANTIGENS, CD40; ANTIGENS, CD56; CD40 LIGAND; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; TUMOR CELLS, CULTURED;

EID: 0030905897     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.12.2053     Document Type: Article

References (58)

1. Herberman, R.B. 1982. NK Cells and Other Natural Effector Cells. Academic Press, New York. 912 pp.
2. Borysiewicz, L.K., B. Rodgers, S. Morris, S. Graham, and J.G.P. Sissons. 1985. Lysis of human cytomegalovirus infected lymphoblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. J. Immunol. 134:2695-2705.
3. Murphy, W.J., V. Kumar, and M. Bennett. 1987. Acute rejection of murine bone marrow allograft by Natural Killer cells and T cells. J. Exp. Med. 166:1499-1503.
4. - lymphocytes in mixed lymphocyte culture. J. Exp. Med. 168:2403-2407.
5. Dorshkind, K., S.B. Pollack, M.J. Bosma, and R.A. Phillips. 1985. Natural Killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J. Immunol. 134: 3798-3801.
6. Mombaerts, P., N. Mizoguchi, H.-G. Ljunggren, J. Iacomini, H. Ishikawa, L. Wang, M.J. Grusby, L.H. Glimcher, H.J. Winn, A.K. Bhan, and S. Tonegawa. 1994. Peripheral lymphoid development and function in TCR mutant mice. Int. Immunol. 134:1061-1070.
7. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules on human natural killer cells. J. Exp. Med. 182:875-884.
8. Mathew, B.A., H. Garni-Wagner, K. Land, A. Takashima, E. Stoneman, M. Bennett, V. Kumar.1993. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC restricted killing mediated by activated NK cells and T cells. J. Immunol. 151:5328-5334.
9. Lanier, L.L., and J.H. Phillips. 1996. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today. 17:86-91.
10. Kane, P.K. 1994. Ly49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J. Exp. Med. 179:1011-1015.
11. Dohring, C., and M. Colonna. 1996. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur. J. Immunol. 26:365-370.
12. Ljunggren, H.-G., and K. Kärre. 1990. In search of the missing self: MHC molecules and NK cell recognition. Immunol. Today. 11:237-244.
13. Gumperz, J.E., and P. Parham. 1995. The enigma of the natural killer cell. Nature (Lond.). 378:245-248.
14. Hoglund, P., C. Ohlen, E. Carbone, L. Franksson, H.-G. Ljunggren, A. Latour, B. Koller, and K. Kärre. 1991. Recognition of β2-microglobulin negative (β2m-) T-cell blast by natural killer cells from normal but not from β2m-mice. Proc. Natl. Acad. Sci. USA. 88:10332-10337.
15. Chambers, B.J., M. Salcedo, and H.-G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity. 5:311-317.
16. Bezouska, K., C.T. Yuen, J. O'Brien, R.A. Childs, W. Chai, A.M. Lawson, K. Drbal, A. Fiserovà, M. Pospisil, and T. Feizi. 1994. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytoxicity. Nature (Lond.). 372:150-157.
17. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69 mediated pathway of lymphocytes activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic-lymphocytes expressing T cell receptor α/β. J. Exp. Med. 174:1393-1398.
18. Dücher, M., M. Offterdinger, H. Holzmüller, J. Lipp, C.T. Chu, B. Aschauer, F.H. Bach, and E. Hofer. 1995. NKG2-C is a receptor on human natural killer cells that recognizes structures on K562 target cells. Eur. J. Immunol. 25:2923-2931.
19. Siliciano, R.F., J.C. Pratt, R.E. Schmidt, J. Ritz, and E.L. Reinherz. 1985. Activation of cytolytic T lymphocytes and natural killer cells function through the T11 sheep eritrocyte binding protein. Nature (Lond.). 317:428-430.
20. Chambers, W.H., N.L. Vujanovic, A.B. Deleo, M.W. Olszowy, R.B. Herberman, and J.C. Hiserodt. 1989. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 169:1373-1389.
21. Lanier, L.L., C. Chang, H. Spits, and J.H. Phillips. 1992. Expression of cytoplasmic CD3∈ protein in activated adult natural killer (NK) cells and CD3 γ, δ, ε complexes in fetal NK cells. J. Immunol. 149:1876-1880.
22. Rodewald, H.R., P. Moingeon, J.L. Lucich, C. Dosiou, P. Lopez, and E.L. Reinherz. 1992. A population of early fetal thymocytes expressing Fcγ RII/III contains precursors of T lymphocytes and natural killer cells. Cell. 69:139-150.
23. Lanier, L.L., J.H. Phillips, J. Hackett, Jr., M. Tutt, and V. Kumar. 1986. Natural killer cells: definition of a cell rather than a function. J. Immunol. 137:2735-2739.
24. Perussia, B. 1991. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr. Opin. Immunol. 3:49-55.
25. Azuma, M., M. Cayabyab, D. Buck, J.H. Phillips, and L.L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115-1123.
26. Clark, E.A. 1990. CD40: a cytokine receptor in search for a ligand. Tissue Antigens. 36:33-39.
27. Schiever, F., A.S. Freeman, G. Freeman, E. Messner, D. Lee, J. Daley, and L.M. Nadler. 1989. Isolated human dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169: 2043-2058.
28. Alderson, M.R., R.J. Armitage, T.W. Tough, L. Strockbine, W.C. Fanslow, and M.K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178:669-674.
29. Smith, C.A., T. Farrah, and G.R. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell. 76:959-962.
30. Camerini, D., G. Walz, W.A.M. Loenen, J. Borst, and B. Seed. 1991. The cell activation antigen CD27 is a member of the NGF/TNF receptor gene family. J. Immunol. 147:3165-3171.
31. Dürkop, H.J., U. Latza, M. Hummel, F. Eitelbach, B. Sead, and H. Stein. 1992. Molecular cloning and expression of a new member of nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 68:421-427.
32. Itoh, N., A. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-245.
33. Foy, T.M., A. Aruffo, J. Bajorath, J.E. Buhlmann, and R.J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591-617.
34. Gaushat, J.F., S. Henchoz, G. Mazzei, J.P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Romo. 1993. Induction of human IgE synthesis in B cells by mast cells and basophilis. Nature (Lond.). 365:340-443.
35. Gauchat, J.F., S. Henchoz, D. Fattah, G. Mazzei, J.P. Aubry, T. Jomotte, L. Dash, K. Page, R. Solari, D. Aldebert, M. Capron, C. Dahinden, and J.Y. Bonnefoy. 1995. CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 25:863-865.
36. Grammer, A.C., M.C. Bergman, Y. Miura, K. Fujita, L.S. Davis, and P.E. Lipsky. 1995. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154: 4996-5010.
37. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. Van Kooten, Y.S. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
38. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, R.S. Rosen, T. Chatila, S.M. Fu, I. Stamenkovic, and R.S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immmunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2173.
39. Farrington, M., L.S. Grosmaire, S. Nonoyama, S.H. Fisher, D. Hollenbaugh, J.A. Ledbetter, R.J. Noelle, J.A. Aruffo, and H.D. Ochs. 1994. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA. 91:1099-1104.
40. Callard, R.E., R.J. Armitage, W.C. Fanslow, and M.K. Spriggs. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today. 14:559-563.
41. Foy, T.M., D.M. Page, T.J. Waldschimidt, J.D. Schoneveld, J.D. Laman, S.R. Masters, L. Tygrett, J.A. Ledbetter, A. Aruffo, E. Claassen et al. 1995. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1377-1388.
42. Ruggiero, G., E. Martìnez Cacères, A. Voordouw, E. Noteboon, D. Graf, R.A. Kroczek, and H. Spits. 1996. CD40 expressed on thymic epithelial cells provides costimulation for proliferation but not for apoptosis of human thymocytes. J. Immunol. 156:3737-3746.
43. + T lymphocytes. J. Immunol. 152:1523-1532.
44. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen specific T cell priming in mice lacking CD40 ligand. Nature (Lond.). 378:617-620.
45. Gray, J.D., and D.A. Horwitz. 1995. Activated human NK cells can stimulate resting B cells to secrete immunoglobulins. J. Immunol. 154:5656-5664.
46. Momburg, F., V. Ortiz-Navarrete, J. Neefjes, E. Goulemy, Y. Van de Wal, P. Walden, and G.J. Hämmerling. 1992. Proteasome subunits encoded by the Major Histocompatibility Complex are not essential for antigen presentation. Nature (Lond.). 360:174-176.
47. Azuma, M.D., M. Cayabyab, D. Buck, J.H. Phillips, and L.L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small resting T cells. J. Exp. Med. 175:353-358.
48. Lanier, L.L., and D. Recktenweld. 1991. Multicolor immunofluorescence and flow cytometry. Methods (Orlando). 2:192-198.
49. Kornblhut, J., N. Flomberg, and B. Dupont. 1982. Cell surface phenotype of cloned line of human Natural Killer cells. J. Immunol. 129:2831-2836.
50. Carbone E., G. Terrazzano, M. Colonna, L. Tuosto, E. Piccolella, L. Franksson, G. Palazzolo, J.J. Perez-Villar, S. Fontana, K. Kärre, and S. Zappacosta. 1996. Natural killer clones recognize specific soluble HLA class 1 molecules. Eur. J. Immunol. 26:683-689.
51. Moretta, A., M. Vitale, C. Bottino, A.M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lyis of MHC class I protected cells in NK clones displaying different specificities. J. Exp. Med. 178:597-604.
52. + T cells. J. Immunol. 151:2497-2510.
53. Snapper, C.M., H. Yamaguchi, M.A. Moorman, R. Sneed, D. Smoot, and J.J. Mond. 1993. Natural killer cells induce activated murine B cells to secrete Ig. J. Immunol. 151:5251-5260.
54. Stüber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin-12 secretion. J. Exp. Med. 183:693-698.
55. Shu, U., M. Kiniwa, C.Y. Wu, C. Malistewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125-1128.
56. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature (Lond.). 378:620-623.
57. Guo, Y., Y. Wu, S. Shinde, M. Sy, A. Aruffo, and Y. Liu. 1996. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J. Exp. Med. 184:955-961.
58. Sanjay, S., Y. Wu, Y. Guo, Q. Niu, J. Xu, I.S. Grewal, R. Flavell, and Y. Liu. 1996. CD40L is important for induction of, but not response to, costimulatory activity. J. Immunol. 157:2764-2768.